Pharmaceutical Industry

Drug Development Drug Pricing Drug Manufacturing Market Trends Manufacturing Generic Drugs Clinical Trials Market Competition Drug Safety Research and Development

U.S. Trade Pressure Puts Swiss Pharma at Risk of Investigation

A U.S. trade probe could force Switzerland to alter drug pricing or face tariffs and spur major drugmakers to invest in U.S. manufacturing.

Moderna Signals Interest in Buying Biontech's German Plants

Hackers Claim More Than 1TB Stolen From Novo Nordisk

Eli Lilly and Boehringer Cut Planned Germany Investments, Signalling Risk to Pharma Hub

Boehringer Ingelheim and Eli Lilly Cut Major Germany Investments

Sanofi Launches 'Concierge for Field' AI Sales Agent Built on Snowflake

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Mangione Supporter Linked to CVS Health Executive After Praising CEO's Killing

Kissei Discloses 20 Deaths in Japan Among Tabneous Users

Dr. Ahorro Shuts All Argentina Pharmacies as Cash Crunch Triggers Court Process

Delhi Police Bust ₹6 Crore Counterfeit Drug Network in Mukherjee Nagar

AstraZeneca Revives UK Plans With £300 Million for Cambridge and Macclesfield

Biocon Targets One in Five Insulin Users as It Pushes for Global Lead

Collegium to Acquire AZSTARYS for $650 Million, Adding Second ADHD Medicine

Roche Expands NVIDIA Partnership, Building Pharma’s Largest Hybrid‑Cloud AI Factory

Roche Launches Nvidia-Powered AI Factory With 2,176 New Blackwell GPUs, Claims Pharma’s Largest Footprint

Eli Lilly to Invest $3 Billion in China to Build Orforglipron Manufacturing

Novo Nordisk Extends Weight‑Loss Lead as Amgen’s Once‑Monthly MariTide Reaches Phase 3

CVS Threatens To Close 134 Tennessee Pharmacies as PBM-Separation Bill Advances

Investor Law Firms Rally uniQure Case as April 13 Lead-Plaintiff Deadline Nears